03
EXPANDING CAPABILITY
VALIDATE
Experimental Direction
Provide in-vitro and in-vivo evidence for prioritized molecules as the platform grows, connecting computational discovery with experimental validation.
SCIENCE FOR A HEALTHIER TOMORROW
Universal Drug Discovery integrates advanced computation and artificial intelligence to discover and prioritize promising therapeutic candidates, with an expanding strategy toward experimental validation and integrated drug discovery.
Real experimental structure
RCSB Protein Data Bank
Unmet Medical NeedsGlobal health impact
Science-DrivenRigorous and transparent
Innovative ApproachFrom data to therapeutics
Real-World ImpactA healthier tomorrow
OUR APPROACH
We explore broad molecular space, prioritize promising candidates, build deeper scientific understanding, and are expanding toward experimental validation to advance new therapeutics.
01
EXPLORE
A locally maintained molecular data resource exceeding 100 billion structures enables high-speed exploration of chemical space through optimized molecular search and retrieval.
Explore capability →EVALUATE
Build quantum-chemical understanding across broad chemical space by integrating advanced AI with complementary ligand- and receptor-based analysis, engineered for scalable large-scale computation.
Explore capability →
03
EXPANDING CAPABILITY
VALIDATE
Provide in-vitro and in-vivo evidence for prioritized molecules as the platform grows, connecting computational discovery with experimental validation.
04
ADVANCE
Address critical global diseases including HIV, flaviviral infections such as dengue, lung cancer, and neurological disorders, with a discovery platform designed to expand across a broader spectrum of therapeutic areas.
OUR RESEARCH
UDD's research spans quantum chemistry, artificial intelligence, molecular datasets, protein–ligand interactions, and therapeutic discovery. QM40 and SmartCADD form two major research pillars, supported by a growing portfolio of peer-reviewed studies.
QUANTUM DATA · MACHINE LEARNING
A realistic quantum-mechanical molecular dataset developed for molecular machine learning, with continued expansion toward next-generation molecular AI.
AI · QM · DRUG DISCOVERY
An AI-QM empowered drug-discovery platform for scalable molecular screening and evaluation, demonstrated in HIV drug discovery and continuing to expand.
PROTEIN–LIGAND · QUANTUM CHEMISTRY
Quantum-chemical research into protein–ligand interactions, bond strength, molecular recognition, and enzyme reactivity.
HIV · DENGUE · ANTIVIRAL DISCOVERY
Therapeutic discovery research spanning HIV and dengue, with computational studies connecting molecular screening, structural analysis, and candidate evaluation.
THERAPEUTIC PROGRAMS
We are applying our discovery platform to important diseases with significant unmet need, starting with HIV, dengue and other flaviviruses, and oncology.
View All Programs →Accelerating discovery of new therapeutic candidates against persistent HIV infection.
Learn More →
CDC / NIAID · CC BY 2.0
Discovering antiviral candidates against dengue and other medically important flaviviruses.
Learn More →
NIH · Public Domain
Advancing molecular discovery against high-value targets in cancer, including lung cancer.
Program in Development
CC0 Photograph
Expanding therapeutic discovery in Batten disease and safer, more effective μ-opioid receptor medicines.
Program in DevelopmentOUR MISSION
Universal Drug Discovery is building an integrated discovery organization that connects molecular data, artificial intelligence, quantum chemistry and therapeutic research.
COLLABORATE WITH UDD
UDD welcomes conversations with researchers, institutions, technology partners and organizations interested in advancing therapeutic discovery.